ECCO'25 Abstracts

ECCO'25 Abstracts on the JCC Website

ECCO'25 Abstract Book PDF Version

ECCO'25 Abstracts COI Disclosure

ECCO'24 Abstracts

ECCO'24 Abstracts on the JCC Website

ECCO'24 Abstract Book PDF Version

ECCO'24 Abstracts COI Disclosure

Poster Presentations: Epidemiology 2023

P826 Economic impact of inflamatory bowel disease in Catalonia. A population-based analysis

P827 SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with Inflammatory Bowel Disease: A systematic review and meta-analysis

P828 Incidence and predictors of arterial and venous thromboembolic events in hospitalized patients with inflammatory bowel disease compared to patients with acute infective gastroenteritis and colitis: a propensity score-matched study.

P829 The Burden of Colorectal Cancer in Patients with Ulcerative Colitis – Incidence and Risk factors from a Population-based Inception Cohort from Veszprem county, Western Hungary, from 1977–2020

P830 Significant racial and ethnic disparities exist in health-care utilization in inflammatory bowel disease: a systematic review and meta-analysis

P831 Clinical factors associated with severity in patients with Inflammatory Bowel Disease in Brazil (On Behalf of GEDIIB)

P832 Cannabis Use in IBD Patients: A Population-Based Study

P833 Cervical cancer risk in newly diagnosed ulcerative colitis: a nationwide population-based study

P834 Physical activity in people with Inflammatory Bowel Disease – towards precision prevention

P835 Visceral adiposity independently predicts time to flare in inflammatory bowel disease, but BMI does not

P836 Trends in the prevalence of Inflammatory Bowel Disease in Lithuania during 2001-2020

P837 Incidence, evolution of disease phenotype, time to biological therapy and medium-, long-term surgery rates in IBD-U patients in Western Hungary – a population-based study between 1977–2020, data from the Veszprem county cohort

P838 Increased Risk of Avascular Necrosis in Patients With Inflammatory Bowel Disease: a nationwide population based cohort study

P839 Clinical activity in inflammatory bowel diseases is associated with consumption of processed foods

P840 Longitudinal bidirectional association of physical activity and disease activity in children with Inflammatory Bowel Disease: a cohort study

P841 Implication of Clostridioides difficile in the diagnosis and evolution of patients with pediatric inflammatory bowel disease.

P842 SARS-CoV-2 antibody titers analysis in immune mediated inflammatory disease patients after COVID-19 vaccination: a monocentric retrospective study.

P843 Mucinous and signet-ring colonic adenocarcinoma in Inflammatory Bowel Disease

P844 Frequency of Extraintestinal Manifestations in vedolizumab versus anti-TNF Treated Patients with Inflammatory Bowel Diseases

P845 Increased incidence of herpes zoster in patients with Inflammatory Bowel Diseases in Europe

P846 Epidemiological and Clinical Characteristics of Inflammatory Bowel Diseases in Patients from Greece

P847 Insomnia is common in IBD and associated with increased disability and abdominal pain

P848 Risk of Orthorexia Nervosa in Patients with Inflammatory Bowel Disease: A Link with Eating Disorders?

P849 Exposure to metals and minerals in hair samples of patients with preclinical inflammatory bowel disease

P850 Co-medication before and after onset of inflammatory bowel disease in adults or elderly

P851 Impact of an integrated model of care for inflammatory bowel disease on direct healthcare costs: A population-based matched cohort study from Saskatchewan, Canada

P852 predictors of complicated disease course in UC in an administrative database: a nationwide study from the epi-IIRN

P853 Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in the Faroe Islands compared to inflammatory bowel disease patients in Eastern and Western Europe – An Epi-IBD study

P854 Race and ethnicity in ulcerative colitis clinical trial enrolment: a post hoc analysis of patient demographics and clinical characteristics from GEMINI 1, VARSITY, and VISIBLE 1

P855 The impact of the severe financial crisis on drug persistence and disease course in IBD patients in Lebanon

P856 Associations of antibiotics, hormonal therapies, oral contraceptives, and long-term NSAIDs with Inflammatory Bowel Disease: results from the Prospective Urban Rural Epidemiology (PURE) study

P858 Prevalence of sarcopenia in patients with inflammatory bowel disease and factors associated with it

P859 Accuracy of self-reporting of immune-mediated inflammatory diseases by patients with inflammatory bowel disease. Results from a hospital-based cohort.

P860 The Costs of Inflammatory Bowel Diseases in High-Income Settings

P861 Frequency and Influence of a Positive Family History on the Clinical Course of Inflammatory Bowel Diseases

P862 Dietary risk factors associated with onset of IBD: a systematic literature review and meta-analysis

P863 Exploring patients’ perceptions of clinical research in inflammatory bowel disease and barriers to participating in clinical trials

P864 Frailty is associated with fatigue in older patients with Inflammatory Bowel Disease.

P865 Anxiety and Depression is Associated with Poor Sleep Quality in patients with Inflammatory Bowel Disease (IBD)

P866 Skin lesions among consecutive Inflammatory bowel disease patients in outpatient setting

P867 Cost-effectiveness and cost-only studies for Inflammatory Bowel Disease surgery: a scoping review

P868 Clinical features of chronic enteropathy associated with SLCO2A1 gene

P869 Prevalence of Depression and Anxiety before and during the COVID-19 Pandemic in Puerto Ricans with Inflammatory Bowel Disease

P870 What had the greatest impact on the quality of life of IBD patients on intravenous biological therapy in Montenegro during COVID-19?

P871 Consideration of smoking and familial aggregation of appendectomy together may change our previous belief about the influence of appendectomy in Inflammatory Bowel Disease (Ulcerative Colitis vs Crohn's Disease).

P872 Underrepresentation of Palestinian Citizens of Israel in Israeli Inflammatory Bowel Disease Trials

P874 Comparison and Propensity Score of Seroconversion After Two Doses Of SARS-CoV-2 Vaccine in IBD Patients And Liver Transplant Recipients

P875 Disease course of Ulcerative Colitis during the first ten years following diagnosis in a prospective European population-based inception cohort – the Epi-IBD cohort

P876 Disease course of Inflammatory Bowel Disease Unclassified in adult patients : a population-based study (1988-2014)

P877 Risk of gastric cancer among patients with incident ulcerative colitis: A nationwide population based study.

P878 Country is the main determinant of differences in nutritional therapy practices across Europe: Results of the Y-ECCO ClinCom Survey 2022

P879 Clinical significance of plasma interleukin-22 as a biomarker of inflammation in patients with Crohn’s disease and ulcerative colitis

P880 High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region

P881 Is occupation a risk factor for developing Inflammatory Bowel Disease? A case-control study.

P882 Regional differences in biologic and surgical treatment of inflammatory bowel disease in Norway 2011–2019

P883 Parental and perinatal risk factors associated with onset of Inflammatory Bowel Disease: A systematic literature review and meta-analysis.

P884 Association between psychosocial factors experienced in childhood or adolescence and occurrence of Inflammatory Bowel Disease (IBD) in adulthood: a case-control study in Quebec, Canada

P885 Does long term corticosteroid use increase the risk of femur fracture in Inflammatory Bowel Disease patients? : A nationwide population-based cohort study

P886 Clinical course and therapeutic management 5 years after diagnosis, in a cohort of Spanish patients with Crohn´s disease diagnosed in the 21st century.

P887 Epidemiology of perianal fistulising Crohn’s disease: a systematic literature review

P888 Evaluating patient access to infliximab subcutaneous in inflammatory bowel disease

P889 Serologic response with antimicrobial antibodies during the preclinical phase of inflammatory bowel disease

P890 Prevalence and Characteristics of Extra-intestinal Manifestations in a single cohort of Italian Patients with Inflammatory Bowel Disease

P891 Estimating diet’s quality in patients with Crohn’s disease during remission

P892 Characteristics and trend of Inflammatory Bowel Disease epidemiology for 30 years from 1991 to 2020: A single-center experience analysis in Incheon, Korea

P893 Budget impact analysis of introducing infliximab subcutaneous for the treatment of Inflammatory Bowel Disease in Latvia

P894 Diagnostic yield of routine stool pathogen tests during the relapse of Inflammatory Bowel Disease

P895 Differences in ulcerative colitis patients regarding COVID-19 status

P896 Inflammatory Bowel Disease in the elderly, a survey of elderly patient demographics, disease-related complications and compliance with vaccination and screening services